Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Assets Average (2016 - 2025)

Lexaria Bioscience's Assets Average history spans 10 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Assets Average fell 45.2% year-over-year to $5.1 million; the TTM value through Nov 2025 reached $5.1 million, down 45.2%, while the annual FY2025 figure was $6.5 million, 9.13% up from the prior year.
  • Assets Average for Q4 2025 was $5.1 million at Lexaria Bioscience, down from $5.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $12.5 million in Q4 2021 and bottomed at $91125.5 in Q2 2023.
  • The 5-year median for Assets Average is $6.8 million (2021), against an average of $6.4 million.
  • The largest annual shift saw Assets Average tumbled 99.11% in 2023 before it skyrocketed 3153.17% in 2025.
  • A 5-year view of Assets Average shows it stood at $12.5 million in 2021, then plummeted by 45.16% to $6.9 million in 2022, then plummeted by 76.96% to $1.6 million in 2023, then surged by 490.51% to $9.3 million in 2024, then crashed by 45.2% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Assets Average are $5.1 million (Q4 2025), $5.5 million (Q3 2025), and $7.7 million (Q2 2025).